Treatment algorithm for IPSS lower-risk MDS. ATG, antithymocyte globulins; CSA, cyclosporine; ESAs, erythropoietic-stimulating agents; G-CSF, granulocyte colony-stimulating factor; HMTs, hypomethylating agents; HSCT, hematopoietic stem cell transplant; ICT, iron chelation therapy.